<DOC>
	<DOCNO>NCT01016639</DOCNO>
	<brief_summary>The purpose study evaluate treatment radio chemotherapy ( oxaliplatin capecitabine ) give concommitant radiotherapy patient gastrointestinal tumor . The trial consist ot two separate study ; CORGI-U patient stomach- bile ducts- gallbladder pancreas cancer , CORGI-L patient colorectal cancer . CORGI-U design phase-I-II-study , first part chemotherapy dose find study , follow phase II part establish response rate . All subject receive radiotherapy concommitant . CORGI-L phase II trial , patient treat chemotherapy fixed dos radiotherapy concommitant .</brief_summary>
	<brief_title>Study Capecitabine Oxaliplatin Combination With Radiotherapy Patients With Unresectable Gastro-Intestinal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<mesh_term>Gallbladder Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Over 18 year age Measurable disease accord RECIST ECOG Performance Status 01 ANC 1.5 x 10 9/L Platelets 100 x 10 9/L Creatinine less 1.5 x ULN Bilirubin le 1.5 x ULN ALT le 2.5 x ULN Signed inform concent Prior radiotherapy local Prior chemotherapy locally advance metastatic disease Pregnancy breast feed Peripheral neuropathy grade 1 Uncontrolled diarrh√©a Other serious uncontrolled concomitant illness Lymph node metastasis include GTV ( gross tumor volume ) , without exceed stipulate radiotherapy dos organ risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Stomach cancer</keyword>
	<keyword>Gall bladder cancer</keyword>
	<keyword>Bile ductus cancer</keyword>
	<keyword>Pancreas cancer</keyword>
	<keyword>Colorectal cancer</keyword>
	<keyword>Chemo radiotherapy</keyword>
	<keyword>Phase I-II</keyword>
	<keyword>Oxaliplatin</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Response</keyword>
</DOC>